{
    "Trade/Device Name(s)": [
        "Tacrolimus Assay Kit"
    ],
    "Submitter Information": "Shanghai Genext Medical Technology Co., Ltd.",
    "510(k) Number": "K203833",
    "Predicate Device Reference 510(k) Number(s)": [
        "K070820"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MLM"
    ],
    "Summary Letter Date": "January 27, 2023",
    "Summary Letter Received Date": "August 19, 2022",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1678"
    ],
    "Regulation Name(s)": [
        "Tacrolimus Test System"
    ],
    "Analyte Class(es)": [
        "toxicology",
        "transplant"
    ],
    "Analyte(s)": [
        "Tacrolimus (FK506)"
    ],
    "Specimen Type(s)": [
        "Whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Beckman Coulter AU480"
    ],
    "Method(s)/Technology(ies)": [
        "Latex-enhanced competitive immunoturbidimetry",
        "Particle-enhanced turbidimetric inhibition immunoassay (PETINIA)"
    ],
    "Methodologies": [
        "Immunoturbidimetry"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Reagent",
        "Sample preparation"
    ],
    "Document Summary": "FDA 510(k) summary for Shanghai Genext Tacrolimus Assay Kit for quantifying tacrolimus in whole blood using latex-enhanced immunoturbidimetry on Beckman Coulter AU480.",
    "Indications for Use Summary": "Quantitative determination of tacrolimus concentration in human whole blood on Beckman Coulter AU480, used to aid in management of liver and kidney allograft patients receiving tacrolimus therapy.",
    "fda_folder": "Clinical Chemistry"
}